Table 1. Messenger RNA Vaccines and Therapeutics Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Messenger RNA Vaccines and Therapeutics Market Restraints

Table 3. Messenger RNA Vaccines and Therapeutics Market Trends

Table 4. Messenger RNA Vaccines and Therapeutics Industry Policy

Table 5. Global Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Company (2018-2023)

Table 7. Global Messenger RNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Messenger RNA Vaccines and Therapeutics Mergers & Acquisitions, Expansion Plans

Table 9. Global Messenger RNA Vaccines and Therapeutics Manufacturers Product Type

Table 10. China Messenger RNA Vaccines and Therapeutics Revenue by Company (2018-2023) & (US$ million)

Table 11. China Messenger RNA Vaccines and Therapeutics Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Messenger RNA Vaccines and Therapeutics Upstream (Raw Materials)

Table 13. Global Messenger RNA Vaccines and Therapeutics Typical Customers

Table 14. Messenger RNA Vaccines and Therapeutics Typical Distributors

Table 15. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Messenger RNA Vaccines and Therapeutics Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Table 22. BioNTech Company Information, Head Office, Market Area and Industry Position

Table 23. BioNTech Company Profile and Main Business

Table 24. BioNTech Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 25. BioNTech Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 26. BioNTech Recent Developments

Table 27. Moderna Company Information, Head Office, Market Area and Industry Position

Table 28. Moderna Company Profile and Main Business

Table 29. Moderna Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 30. Moderna Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 31. Moderna Recent Developments

Table 32. CureVac Company Information, Head Office, Market Area and Industry Position

Table 33. CureVac Company Profile and Main Business

Table 34. CureVac Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 35. CureVac Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 36. CureVac Recent Developments

Table 37. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 38. Pfizer Company Profile and Main Business

Table 39. Pfizer Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 40. Pfizer Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 41. Pfizer Recent Developments

Table 42. Glaxo Smith Kline's Company Information, Head Office, Market Area and Industry Position

Table 43. Glaxo Smith Kline's Company Profile and Main Business

Table 44. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 45. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 46. Glaxo Smith Kline's Recent Developments

Table 47. Daiichi Sankyo Company Company Information, Head Office, Market Area and Industry Position

Table 48. Daiichi Sankyo Company Company Profile and Main Business

Table 49. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 50. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 51. Daiichi Sankyo Company Recent Developments

Table 52. Intellia Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Intellia Therapeutics Company Profile and Main Business

Table 54. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 55. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 56. Intellia Therapeutics Recent Developments

Table 57. Arcturus Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 58. Arcturus Therapeutics Company Profile and Main Business

Table 59. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 60. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 61. Arcturus Therapeutics Recent Developments

Table 62. Emmy Vaccine Company Information, Head Office, Market Area and Industry Position

Table 63. Emmy Vaccine Company Profile and Main Business

Table 64. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 65. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 66. Emmy Vaccine Recent Developments

Table 67. CSPC Company Information, Head Office, Market Area and Industry Position

Table 68. CSPC Company Profile and Main Business

Table 69. CSPC Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 70. CSPC Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 71. CSPC Recent Developments

Table 72. CanSino Company Information, Head Office, Market Area and Industry Position

Table 73. CanSino Company Profile and Main Business

Table 74. CanSino Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 75. CanSino Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 76. CanSino Recent Developments

Table 77. Fosun Pharma Company Information, Head Office, Market Area and Industry Position

Table 78. Fosun Pharma Company Profile and Main Business

Table 79. Fosun Pharma Messenger RNA Vaccines and Therapeutics Models, Specifications and Application

Table 80. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue and Gross Margin, 2018-2023

Table 81. Fosun Pharma Recent Developments

List of Figure

Figure 1. Messenger RNA Vaccines and Therapeutics Picture

Figure 2. Global Messenger RNA Vaccines and Therapeutics Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Messenger RNA Vaccines and Therapeutics Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Messenger RNA Vaccines and Therapeutics Market Share of Global

Figure 5. Global Messenger RNA Vaccines and Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Messenger RNA Vaccines and Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Messenger RNA Vaccines and Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Messenger RNA Vaccines and Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Messenger RNA Vaccines and Therapeutics Industry Chain

Figure 10. Self-amplifying

Figure 11. Conventional Non-amplifying

Figure 12. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 14. Cancer

Figure 15. Infectious Diseases

Figure 16. Autoimmune Diseases

Figure 17. Others

Figure 18. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 20. By Region, Global Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2029

Figure 21. North America Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 23. Europe Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 27. South America Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Messenger RNA Vaccines and Therapeutics Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 32. By Type, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 34. Europe Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 36. By Type, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 38. China Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 40. By Type, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 42. Japan Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 44. By Type, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 48. By Type, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 54. India Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 56. By Type, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Messenger RNA Vaccines and Therapeutics Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Messenger RNA Vaccines and Therapeutics Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches